Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-15-013755
Filing Date
2015-02-13
Accepted
2015-02-13 17:39:54
Documents
1
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 5 SUBMISSION doc5.html 5  
1 FORM 5 SUBMISSION doc5.xml 5 10897
  Complete submission text file 0001209191-15-013755.txt   12439
Mailing Address 801 CORPORATE CENTER DRIVE SUITE 210 RALEIGH NC 27607
Business Address 801 CORPORATE CENTER DRIVE SUITE 210 RALEIGH NC 27607 919 582 9050
BIODELIVERY SCIENCES INTERNATIONAL INC (Issuer) CIK: 0001103021 (see all company filings)

EIN.: 352089858 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O BIODELIVERY SCIENCES INTERNATIONAL 801 CORPORATE CENTER DRIVE -SUITE 210 RALEIGH NC 27607
Business Address
Sirgo Mark A (Reporting) CIK: 0001301715 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-31361 | Film No.: 15616614